Medicare Enrolled
Dr. Abraham Abittan, M.D.
Optician · Woodmere, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abittan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abittan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abittan
Dr. Abraham Abittan is an optician specialist in Woodmere, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Abittan performed 73,879 Medicare services across 5,145 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abittan received a total of $42,366 from 32 pharmaceutical and/or device companies across 456 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abittan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in NY
$42,366 industry payments
Medicare Practice Summary
Medicare Utilization ↗73,879
Medicare services
Top 1% in NY for optician
5,145
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,888 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 52,404 | $1 | $2 |
| Triamcinolone acetonide injection, 1 mg An injection of triamcinolone acetonide, a corticosteroid medication, administered in a 1 mg dose without preservatives. |
5,566 | $3 | $4 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
5,346 | $6 | $45 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,091 | $83 | $152 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
1,659 | $50 | $130 |
| Allergy skin patch test A diagnostic test where small amounts of potential allergens are applied to the skin to identify substances that cause an allergic reaction. |
1,648 | $5 | $20 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
1,104 | $4 | $15 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
700 | $91 | $575 |
| Laser treatment for inflammatory skin disease, 250-500 sq cm This procedure uses a laser to treat inflammatory skin conditions covering an area between 250 and 500 square centimeters. |
461 | $161 | $575 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
455 | $35 | $95 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
397 | $267 | $500 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
266 | $104 | $225 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
253 | $48 | $550 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
217 | $306 | $500 |
| Injection into skin growths, more than 7 A procedure involving the injection of medication into more than seven skin growths. |
182 | $44 | $150 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
150 | $115 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
115 | $118 | $225 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
113 | $163 | $550 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
98 | $13 | $125 |
| Complex or multiple skin abscess drainage A procedure to drain one or more skin abscesses that are complex in nature. This involves opening and cleaning the infected pockets under the skin. |
85 | $204 | $375 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
62 | $104 | $250 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 56 | $394 | $650 |
| Removal of inflamed or infected skin, up to 10% of body surface This procedure involves the surgical removal of skin affected by inflammation or infection. It is performed when the affected area covers up to 10 percent of the patient's total body surface area. |
52 | $45 | $125 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
46 | $648 | $1,200 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
41 | $74 | $250 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
38 | $117 | $300 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
35 | $98 | $175 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $155 | $275 |
| Fingernail or toenail biopsy A small sample of tissue is taken from a fingernail or toenail for laboratory examination. |
29 | $110 | $250 |
| Eyelid biopsy A procedure to remove a small sample of tissue from the eyelid for laboratory examination. |
29 | $177 | $395 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $51 | $81 |
| Additional Mohs surgery stage with microscopic exam This procedure involves the removal and microscopic examination of an additional stage of tissue from the trunk, arms, or legs. It is performed in stages to ensure complete removal of the growth. |
22 | $377 | $1,200 |
| Skin growth removal and lab exam, 1-5 blocks A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination. |
21 | $608 | $1,200 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
19 | $171 | $285 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
18 | $396 | $600 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
17 | $371 | $650 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
15 | $166 | $295 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
12 | $196 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
10.0% medium
89.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$42,366
Total received (2018-2024)
Avg $6,052/year across 7 years
Top 6% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
456
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$33,449 (79.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,266 (17.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,652 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,107
2023
$1,988
2022
$964
2021
$3,802
2020
$2,781
2019
$7,008
2018
$23,716
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Arcutis Biotherapeutics, Inc.
$935
Dermavant Sciences, Inc.
$358
E.R. Squibb & Sons, L.L.C.
$292
PFIZER INC.
$129
Regeneron Healthcare Solutions, Inc.
$98
Novartis Pharmaceuticals Corporation
$77
ABBVIE INC.
$73
UCB, Inc.
$44
Janssen Biotech, Inc.
$44
REVANCE THERAPEUTICS, INC.
$37
Biofrontera Inc.
$20
Top 3 companies account for 75.2% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$24,169
PFIZER INC.
$4,901
Amgen Inc.
$4,434
Janssen Biotech, Inc.
$2,367
Arcutis Biotherapeutics, Inc.
$1,132
Dermavant Sciences, Inc.
$871
E.R. Squibb & Sons, L.L.C.
$820
Medimetriks Pharmaceuticals, Inc.
$730
MERZ NORTH AMERICA, INC.
$516
Novartis Pharmaceuticals Corporation
$380
UCB, Inc.
$324
Regeneron Healthcare Solutions, Inc.
$268
ABBVIE INC.
$208
AbbVie, Inc.
$170
Galderma Laboratories, L.P.
$157
AbbVie Inc.
$143
NOVARTIS PHARMACEUTICALS CORPORATION
$138
GENZYME CORPORATION
$138
Journey Medical Corporation
$125
LEO Pharma Inc.
$84
Smith+Nephew, Inc.
$50
REVANCE THERAPEUTICS, INC.
$37
Merz North America, Inc.
$36
Ortho Dermatologics, a division of Bausch Health US, LLC
$31
Biofrontera Inc.
$24
Almirall LLC
$18
Allergan Inc.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
EPI Health, LLC
$16
PruGen, Inc. Pharmaceuticals
$16
Allergan, Inc.
$15
Taro Pharmaceuticals USA, Inc.
$15
Top 3 companies account for 79.1% of all-time payments
Associated products mentioned in payments ›
AKLIEF · AMELUZ · ANGLED BLADE PLATES · Ameluz · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · COLLAGENASE SANTYL · COSENTYX · Cimzia · Clodan · DAXXIFY · DUOBRII · DUPIXENT · ENSTILAR · EPIDUO FORTE · EUCRISA · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · Ilumya · Neo-Synalar · Neo-Synalar Cream · Neo-Synalar Cream Kit · ORACEA · Otezla · REMICADE · RINVOQ · SKYRIZI · Seysara · Sotyktu · TREMFYA · Tremfya · USP) 0.1% · VTAMA · XEOMIN · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for optician in NY.
Geographic Context
Opticians within 10 mi
15,546
Per 100K population
1119.9
County median income
$143,408
Nearest hospital
ST JOHN'S EPISCOPAL HOSPITAL AT SOUTH SHORE
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abittan is a mixed practice specialist, with above-average Medicare volume (top 1% in NY), with speaking/promotional industry engagement in the top 6% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abittan experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Abittan performed 52,404 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abittan receive payments from pharmaceutical companies?
Yes. Dr. Abittan received a total of $42,366 from 32 companies across 456 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abittan's costs compare to other opticians in Woodmere?
Dr. Abittan's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abittan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Woodmere
Browse opticians in Woodmere ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology